|
Pronunciation |
|
(his
toe PLAZ
min) |
|
|
U.S. Brand
Names |
|
Histolyn-CYL®
Injection |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Histoplasmosis Skin Test Antigen |
|
|
Pharmacological Index |
|
Diagnostic Agent |
|
|
Use |
|
Diagnosing histoplasmosis; to assess cell-mediated
immunity |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Adverse
Reactions |
|
1% to 10%:
Local: Ulceration or necrosis may occur at test site
Respiratory: Dyspnea |
|
|
Stability |
|
Store in refrigerator |
|
|
Usual Dosage |
|
Adults: Intradermally: 0.1 mL of 1:100 dilution into volar surface of
forearm; induration of greater than or equal to 5 mm in diameter indicates a
positive reaction |
|
|
Administration |
|
Use a 3/8
" to 1/2
" 26- or 27-gauge needle |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Test must be read at 24-48 hours or 48-72 hours |
|
|
Nursing
Implications |
|
Examine reaction site at 24-48 hours for cell-mediated immunity and 48-72
hours for histoplasmosis; use a
3/8
" to 1/2
" 26- or 27-gauge needle |
|
|
Dosage Forms |
|
Injection: 1:100 (0.1 mL, 1.3
mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|